Home | Community | Get Involved | Donate | | Site Index | Search Go Button
The mark, American Cancer Society, is a registered trademark of the American Cancer Society, Inc., and may not be copied, reproduced, transmitted, displayed, performed, distributed, sublicensed, altered, stored for subsequent use or otherwise used in whole or in part in any manner without ACS's prior written consent.
 
My Planner Register | Sign In Sign In


    Fact Sheets
    Tobacco Control Country Profiles
    National Action Plan for Childhood Cancer
    Colorectal Cancer Screening Resource Kit
    Tools for Health Insurance Plans
    Pain Management Pocket Tool
    State of the Science on Cancer Survivorship
   
   
   
   
   
   
   
   
    I Want to Help
  You can help in the fight against cancer. Donate and volunteer. It's easy and fun!
  Learn more
   
Clinician's Information Source:
Recent Risk and Screening Articles
Screening increases the odds that colorectal cancers will be found at a localized stage, when the 5-year survival rate is 90%, and reduces the number of cases found with distant spread, when only 10% of patients survive 5 years after diagnosis. Furthermore, screening can identify polyps, which if removed can prevent colorectal cancer from developing. If all adults 50 and older were screened for colon cancer, we could cut the death rate from this disease in half—saving approximately 25,000 lives per year.

Read the articles below for updates on new methods and procedures for colorectal screening and more detailed information on risk factors.

Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology
CA: A Cancer Journal for Clinicians 2008
Accuracy of CT Colonography for Detection of Large Adenomas and Cancers
New England Journal of Medicine 2008
Five-Year Risk of Colorectal Neoplasia after Negative Screening Colonoscopy
New England Journal of Medicine 2008
Prevalence of Colon Polyps Detected by Colonoscopy Screening in Asymptomatic Black and White Patients
JAMA 2008
Stool DNA and Occult Blood Testing for Screen Detection of Colorectal Neoplasia
Annals of Internal Medicine 2008
Screening for Colorectal Cancer: U.S. Preventive Services Task Force Recommendation Statement
Annals of Internal Medicine 2008
Underuse of Colorectal Cancer Screening in a Cohort of Medicare Beneficiaries
Cancer 2008
How to Increase Colorectal Cancer Screening Rates in Practice
CA: A Cancer Journal for Clinicians 2007
Guidelines for Colonoscopy Surveillance after Polypectomy: A Consensus Update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society
CA: A Cancer Journal for Clinicians 2006
Guidelines for Colonoscopy Surveillance after Cancer Resection: A Consensus Update by the American Cancer Society and US Multi-Society Task Force on Colorectal Cancer
CA: A Cancer Journal for Clinicians 2006
A National Survey of Primary Care Physicians' Methods for Screening for Fecal Occult Blood
Annals of Internal Medicine 2005
Accuracy of Screening for Fecal Occult Blood on a Single Stool Sample Obtained by Digital Rectal Examination: A Comparison with Recommended Sampling Practice
Annals of Internal Medicine 2005

Guidelines for Colorectal Cancer Screening for Individuals at Average Risk

Beginning at age 50, both men and women at average risk for developing colorectal cancer should use one of the screening tests below:

Tests That Find Polyps and Cancer

  • Flexible sigmoidoscopy every 5 years*
  • Colonoscopy every 10 years
  • Double contrast barium enema every 5 years*
  • CT colonography (virtual colonoscopy) every 5 years*

Tests That Mainly Find Cancer

  • Guaiac-based fecal occult blood test (gFOBT) every year*,**
  • Fecal immunochemical test (FIT) every year*,**
  • Stool DNA test (sDNA), interval uncertain*

*Colonoscopy should be done if test results are positive.
**For gFOBT or FIT used as a screening test, the take-home multiple sample method should be used. A gFOBT or FIT done during a digital rectal exam in the doctor's office is not adequate for screening.

Read the full guidelines in CA: A Cancer Journal for Clinicians



 
Help |  About ACS |  Employment & Volunteer Opportunities |  Legal & Privacy Information |  Press Room
Copyright 2009 © American Cancer Society, Inc.
All content and works posted on this website are owned and
copyrighted by the American Cancer Society, Inc. All rights reserved.